Rite Aid EBIT

Rite Aid (RAD) currently reports a EBIT of $-480M as of August 2023. That compares with $-5.3M in the prior-year period — down 8869.7% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Rite Aid's EBIT history and peer comparisons.

Rite Aid's EBIT decreased from $-5.3M to $-480M — a 8869.7% year-over-year decrease (period ending August 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rite Aid's EBIT of $-480M is lower than the Healthcare sector average of $23B. That is roughly 102.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Rite Aid reported $-480M in EBIT as of August 2023. That compares with $-5.3M in the prior-year period — down 8869.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-480M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Rite Aid, and consider following RAD for alerts when major investors trade the stock.